Merck Group Competitors and Similar CompaniesClear all
Merck Group's competitors and similar companies include Pfizer, AbbVie and Bristol Myers Squibb.
 Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  AbbVie AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies. |  Bristol Myers Squibb Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products. | ||
Founding Date | Founding Date 1668 | Founding Date 1849 | Founding Date 2013 | Founding Date 1887 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Darmstadt, DE HQ Buenos Aires, AR Bayswater, AU Macquarie Park, AU Wien, AT Hoeilaart, BE Rio De Janeiro, BR see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations North Chicago, US HQ Hydra, DZ Buenos Aires, AR Mascot, AU Wien, AT Wavre, BE Sarajevo, BA see more | Locations Princeton, US HQ Mulgrave, AU Pinewood, AU Wien, AT Braine L'alleud, BE Bruxelles, BE São Paulo, BR see more |
Employees | Employees 62,34615% decrease | Employees 81,0008% decrease | Employees 55,00010% increase | Employees 34,100 |
Valuation ($) | Valuation ($) 71.6 b | Valuation ($) 163.9 b | Valuation ($) 335 b | Valuation ($) 97.8 b |
Financial | ||||
Revenue (est.) | Revenue (est.) €21.1b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $61.2b (FY, 2025) | Revenue (est.) $48.2b (FY, 2025) |
Cost of goods | Cost of goods €6.5b (FY, 2025) | Cost of goods $16.1b (FY, 2025) | Cost of goods $18.2b (FY, 2025) | Cost of goods $13.9b (FY, 2025) |
Gross profit | Gross profit €15b (FY, 2025) | Gross profit $46.5b (FY, 2025) | Gross profit $43b (FY, 2025) | Gross profit $34.3b (FY, 2025) |
Net income | Net income €2.6b (FY, 2025) | Net income $7.8b (FY, 2025) | Net income $4.2b (FY, 2025) | Net income $7.1b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries 66 (FY, 2021) | Countries 200 (FY, 2024) | Countries 70 (FY, 2022) | Countries N/A |
Manufacturing Facilities | Manufacturing Facilities N/A | Manufacturing Facilities N/A | Manufacturing Facilities 19 (FY, 2022) | Manufacturing Facilities 8 (FY, 2021) |
Research and Development Centers | Research and Development Centers N/A | Research and Development Centers N/A | Research and Development Centers 14 (FY, 2020) | Research and Development Centers 11 (FY, 2021) |
Funding | ||||
Total funding raised | Total funding raised $ 121m | Total funding raised N/A | Total funding raised $ 3.8b | Total funding raised $ 15.5m |
For sources of this data, please see the company profile
View Company Profiles
Pfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyAbbVie
HQ
North Chicago, US
Employees
55,000↑ 10% increase
AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies.
View companyBristol Myers Squibb
HQ
Princeton, US
Employees
34,100
Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products.
View company